Navigation Links
Newer Drugs Beat Gleevec in Head-to-Head Trials
Date:6/5/2010

More chronic myeloid leukemia patients responded to Sprycel and Tasigna than Gleevec

SATURDAY, June 5 (HealthDay News) -- Two new drugs, dasatinib (Sprycel) and nilotinib (Tasigna), appear better than imatinib (Gleevec) in treating patients with newly diagnosed chronic myeloid leukemia and should be considered as first-line treatments, two new studies show.

The findings, which should change clinical practice, are to be presented Saturday at the American Society of Clinical Oncology annual meeting in Chicago and were simultaneously published online June 5 in the New England Journal of Medicine.

"Both next-generation inhibitors of BCR-ABL [dasatinib and nilotinib] are superior to Gleevec in treating chronic myeloid leukemia when compared head-to-head after one year of follow-up," said Dr. Charles L. Sawyers, chair of the Human Oncology and Pathogenesis Program at the Howard Hughes Medical Institute at Memorial Sloan-Kettering Cancer Center in New York City and author of an accompanying journal editorial.

"This magnitude of success -- beating a drug like imatinib [Gleevec] that was already pretty great -- is possible because we have a very precise understanding of the drug target BCR-ABL and of the mechanisms of resistance to imatinib," Sawyers added.

Newly diagnosed chronic myeloid leukemia patients should probably now be treated with one of the new drugs instead of imatinib, he noted.

In the first study, a team led by Dr. Hagop Kantarjian, chairman of the leukemia department at the University of Texas M.D. Anderson Cancer Center in Houston, randomly assigned 519 patients to Sprycel or Gleevec.

After a year, 77 percent of the patients receiving Sprycel had a complete cytogenetic response, compared with 66 percent of the patients receiving Gleevec, the researchers found.

Complete cytogenetic response is the disappearance of all the cancer cells from the bone marrow, Kanta
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan
2. Newer Drug More Effective in Psoriasis Treatment
3. Newer cornea transplant surgery shows short- and long-term promise
4. Newer Blood Test Predicts Diabetes, Heart Disease
5. Newer Genetic Test for Autism More Effective
6. Newer Blood Thinner Beats Plavix for Bypass Patients
7. Newer Genetic Info Adds Little to Predicting Breast Cancer
8. In infant heart surgery, newer technique yields better survival in first year of life
9. New Drugs, New Combinations Fight Breast Cancer
10. NICE guidelines ration affordable osteoporosis drugs
11. Bone Drugs May Beat Back Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Tickets announces that Paul McCartney will be performing ... This well known ticket website has slashed prices across ... fans see Sir Paul live in concert. Jan, the ... offering the customer appreciation code SAVE for additional savings on ... also a huge McCartney fan and plans to see him ...
(Date:5/23/2013)... (HealthDay News) -- Schools should ensure that kids ... each day to support their health and boost ... Although previous studies show 60 minutes ... and development, it,s estimated that only about 50 ... recommendation, according to the report from the Institute ...
(Date:5/23/2013)... (HealthDay News) -- Symptoms of borderline personality disorder ... diagnosis and treatment. But researchers in Canada say ... unique to borderline personality disorder: a tendency to ... "They have difficulty processing facial emotions and will ... said Anthony Ruocco, a clinical neuropsychologist and assistant ...
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) ... as badly as methamphetamine or crack cocaine, a new ... ,meth mouth, or ,coke mouth, it is startling to ... less the same," said Dr. Mohamed Bassiouny, a professor ... Dentistry in Philadelphia. Methamphetamine, crack cocaine and soda ...
(Date:5/23/2013)... News) -- Although a study in 2012 suggested ... memory problems associated with Alzheimer,s disease, three groups ... to duplicate those findings. The teams said ... safety since the drug involved in the study, ... major blood-lipid abnormalities, pancreatitis, headaches, fatigue, weight gain, ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets: Prices Slashed on Paul McCartney Tickets in Austin, Brooklyn, Tulsa, Memphis Washington DC, Milwaukee, Boston, Indianapolis, Regina and Seattle 2Health News:U.S. School Kids Should Get Hour of Exercise Daily: Report 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 2Health News:People With Borderline Personality Disorder May Misinterpret Facial Emotions 3Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 2Health News:Diet Soda Habit as Bad for Teeth as Meth Addiction, Study Claims 3Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2
... ANN ARBOR, Mich. Head and neck cancer patients ... more symptoms of chronic pain and complaints of dry mouth ... the University of Michigan Comprehensive Cancer Center. Because these ... that reducing these factors in head and neck cancer patients ...
... touchscreens, housed in computer kiosks at clinics and ... School of Medicine and clinicians at local health ... diverse language, literacy and computer skills. The ... and collect patient data. Each piece of text ...
... Gordon HealthDay Reporter , FRIDAY, July 9 (HealthDay ... and well-being of America,s children, a group of 22 federal ... pregnancies in particular, but bad news in other areas, like ... is a status update on how our nation,s children are ...
... Researchers at Brown University have found that the length of ... doubled during the last 10 years. The study, which will ... the American Geriatrics Society , evaluated hospice use in U.S. ... treatment time has increased from 46 to 93 days. The ...
... ... used cosmetic lasers and other used aesthetic equipment by more than 30% to meet the ... to their patients. , ... Ft. Lauderdale, FL (PRWEB) July 9, 2010 -- The Laser Warehouse has increased its ...
... ... in 2002, the association has accredited certification bodies that represent more than ... Medical Sales Representatives) RMSR Certification has been recently cited with the U. ... sole approved accreditor of certification bodies for entry level Medical Device & ...
Cached Medicine News:Health News:Pain, dry mouth may play role in sleep quality of head and neck cancer patients 2Health News:Pain, dry mouth may play role in sleep quality of head and neck cancer patients 3Health News:Talking touchscreens aid patients 2Health News:U.S. Report on Kids' Health Brings Mixed Results 2Health News:U.S. Report on Kids' Health Brings Mixed Results 3Health News:Study: Medicare policy may account for growing length of hospice stays in nursing homes 2Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 2Health News:The Laser Warehouse Increases its Inventory of Used Cosmetic Lasers to Meet Growing Demand 3Health News:RMSR Certification Gains Medical Device & Equipment Industry Acceptance for Medical Sales Reps 2Health News:RMSR Certification Gains Medical Device & Equipment Industry Acceptance for Medical Sales Reps 3
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... 2013 Halozyme Therapeutics, Inc. (NASDAQ: ... David A. Ramsay as ... Vice President, Corporate Development at Halozyme. ... his established financial management experience and his recent ... our commercial group for the last four years, ...
(Date:5/23/2013)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), ... present a company overview at the Deutsche Bank 38 th ... 2013 at 8:40 a.m. ET in Boston, MA. ... presentation will be available on the "Investors & Media" section ... will be available on the Isis Web site within 48 ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference 2
... Advanced Life Sciences,Holdings, Inc. (Nasdaq: ADLS ... with the National Institute of Allergy and ... biodefense,research, under which the NIAID will conduct ... as a treatment for,anthrax and other high-priority ...
... Compound, AHLi-11, Slated for IND Filing By ... ... Quark Pharmaceuticals, Inc., a,clinical-stage biopharmaceutical company focused on discovering and,developing novel ... the State University of New York at,Buffalo, Center for Hearing & ...
Cached Medicine Technology:Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 2Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 3Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss 4
85 left angled suture passer....
85 right angled suture passer....
... Medical Record organizes communication and chart ... outside practitioners. It also manages orders, ... data that traditionally rely on many ... chart. With Microsoft Outlook integration, HealthMatics ...
... TwinFix AB with its unique thread design ... repair, combining high resistance to pull out, ... absorbability, and application flexibility. This provides the ... soft tissue to bone. , ,The TwinFix ...
Medicine Products: